GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
House Democrats publicly distance themselves from Texas candidate Maureen Galindo after her social media posts calling for ICE centers to become prisons for "American Zionists."...
Willy Medina, a Rhode Island teen who was already out on bail for a weapons offense, has been arrested in connection with a stabbing at a crowded beach earlier this week that sent beachgoers fleeing i...
A suspected drug smuggler was arrested at the Port of Los Angeles after authorities allegedly found $6.4 million worth of cocaine aboard an oil tanker destined for a Mexican cartel....
